A 39 year old man presented with gynaecomastia, loss of libido and high blood pressure. Hormone studies revealed elevated plasma levels of oestradiol and its precursors, which increased in response to adrenocorticotrophic hormone and were reduced to normal levels with dexamethasone.
Introduction
Feminizing tumours of the adrenal cortex are rare and usually malignant neoplasms.' They are almost exclusively confined to middle-aged men and produce symptoms that reflect the oestrogen excess and androgen deficiency-gynaecomastia, diminished libido and testicular atrophy.2 As in other adrenal tumours, there is no close relationship between the histopathology and the biological behaviour of the neoplasm. 3 We present a patient with a feminizing adrenocortical adenoma after a post-resection follow-up period of over 9 years. Hormone production by the tumour was unexpectedly suppressible with dexamethasone. We present its hormone pattern and discuss the different parameters used to differentiate the biological behaviour ofadrenocortical tumours.
Case report A 39 year old man was evaluated for a 5 year history of progressive bilateral gynaecomastia and diminished libido without impotence. His right testicle was cryptorchid at birth and had never descended into the scrotum. Physical examination revealed no features of Cushing's syndrome. Blood pressure was 180/120 mmHg. Breasts were Tanner's stage IV, without tenderness or galactorrhea; no palpable abdominal masses were felt and sexual hair had a feminine distribution with absence of thoracic hair. The right testicle was not palpable and the left had a soft consistency and a volume of 20 cm. Blood count, urinalysis and blood biochemistry, as determined in the SMA-12 autoanalyser, and plain X-rays of the chest, abdomen and skull were normal. Serum levels ofP-human chronic gonadotrophin, a-fetoprotein and carcinoembryonic antigen were undetectable. Urinary vanillylmandelic acid and total metanephrine excretion were normal, as was urinary excretion of free cortisol. Other hormone studies are shown in Table  I . Baseline serum levels of oestradiol (E2), progesterone (P) and 17-hydroxyprogesterone (1 70H-P) were elevated but plasma testosterone levels were normal, as was urinary excretion of 17-ketosteroids (17KS). Intravenous infusion of P1-24 corticotrophin (ACTH; 0.25 mg) for 8 hours produced substantial increases in the levels of E2, P, 1 70H-P and 17KS with no change in testosterone. Dexamethasone 0.5 mg/6 hours for 2 days decreased the levels of E2, P and 170H-P to normal values and suppressed the plasma cortisol value to below 140 nmol/l. Intramuscular injection of human chorionic gonadotrophin (hCG) (5,000 IU daily for 3 days), performed 2 weeks after dexamethasone administration, did not change any hormonal values. Plasma luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels were low to normal, with response to luteinizing hormone releasing hormone (LHRH) (100 lag IV, bolus) ( Table II) . The plasma aldosterone level was 0.92 nmol/l (normal upright value: 0.1 1-0.84) and upright plasma renin activity while on a low sodium diet was 2.35 ng/l/second (normal value: 1.1-2.25), both slightly increased. Chromosomal karyotype was 46XY. Computed tomography (CT) of the abdomen revealed a homogeneous mass in the left adrenal gland measuring 5-6 cm in diameter ( Figure 1 ). The right testicle was not sulated, measured 5 x 4 x 4.5 cm and weighed 84 g. Histologically, it was composed of cells with finely granular cytoplasm, similar to those found in the zona fasciculata of the adrenal cortex. Mitoses were not present and there was no evidence of capsular or vascular invasion (Figure 2) .
Postoperatively, the basal levels of all measured steroids as well as the responses to ACTH and dexamethasone were within normal range (Table  III) . Three months after surgery, the CT was normal and the aldosterone and renin levels had become normal. The values of FSH and LH showed a greater response to LHRH (Table II) . In subsequent check-ups, his libido and body hair increased progressively. The gynaecomastia decreased partially in the first 3 months, subsequently requiring bilateral mammoplasty. Four months after surgery, the ejaculate sperm count was 20.2 million/ml, 70% with spontaneous motility. Nine years later, the patient is asymptomatic, normotensive with normal hormone levels. This latter mechanism would explain the absence of responses of testosterone to hCG in our patient, despite it being testosterone of testicular origin; as shown by its lack of increase after the infusion of ACTH. At the same time, the increase in the hepatic synthesis of sex hormone-binding globulin induced by hyperoestrogenism would explain the total testosterone determinations being within the normal range.
Hypertension is occasionally present in feminizing adrenal tumours,' and is usually secondary to the tumour secretion of mineralocorticoids, mainly desoxycorticosterone'3 and sometimes aldosterone.'4 In our case, the non-suppressed renin value excludes the possibility of an autonomous production of mineralocorticoids. We believe that the arterial hypertension, which disappeared following excision of the tumour, could be a consequence of the oestrogen excess. These hormones increase the hepatic synthesis of renin substrate, which leads to an increase in plasma angiotensin II and aldosterone'5 levels.
Some authors have suggested excessive extraglandular aromatization of precursors to explain the increased oestrogen levels in these tumours.8' 6 7 The return of oestradiol to normal levels and the disappearance of its increase in response to ACTH after surgery is in agreement with tumour production in our case.
Adrenal tumours may be relatively or absolutely deficient in one or more enzymes involved in normal steroidogenesis, such as 21 -hydroxylase, 1 lp-hydroxylase or 3p-hydroxysteroid dehydrogenase.'8 The lack of cortisol hypersecretion or an autonomous production of mineralocorticoids, in spite of the increased availability of precursors in our patient, suggests a 21-hydroxylase deficit.
The secretion of oestrogens and their precursors in response to ACTH has been reported previously In spite of their capacity to respond to exogenous ACTH, most tumours derived from steroidogenic tissue function independently of trophic hormone control. The patient reported here is unusual because the administration of dexamethasone reduced oestradiol and its previously elevated precursors to normal levels. This suggests that the tumour hormone production was at least partially dependent on pituitary ACTH.
In the literature reviewed, there is only one report of an oestrogen-producing adrenal tumour whose levels were partially reduced with dexamethasone.5 These authors suggested that the aromatase activity of the tumour was either dependent on ACTH or directly inhibited by dexamethasone, as in other tissues under experimental conditions.23 This latter mechanism cannot be applied in our case because dexamethasone reduced not only oestradiol, but progesterone and hydroxy-progesterone as well, which is not explained by changes in the aromatase activity alone. Perhaps some cases of adrenocortical feminizing syndrome, initially described as nontumoural,24 were adenomas susceptible to suppression by dexamethasone and invisible to the radiological techniques available at the time.
Differentiation between benign and malignant tumours of the adrenal glands still remains the main problem and only the existence of metastases is a reliable indicator of malignancy. The regular density of CT (with no necrosis or calcification),25 a tumour weight of less than 30 g,26 the absence of mitoses, cellular pleomorphism and vascular or capsular invasion on microscopic examination,27 as well as urinary 17 ketosteroid levels below 20 mg/ day21'28 and, in some series, the response to ACTH,2' are characteristic of benign tumours. Our patient demonstrated all these features with the exception of the tumour weight (84 g). However, the long follow-up period without recurrence supports the benign nature in this case. Finally, the application of modern chromatographic techniques in the analysis of the urinary steroid profile,29'30 flow cytometry analysis of the tumour tissue'6 and the study of the steroid profile of the aldosterone synthesis pathway3' provide new approaches for the differential diagnosis.
In summary, we present a further case offeminizing adrenal adenoma where hormone synthesis depended, at least in part, on the endogenous ACTH. This is exceptional and illustrates a failure in the dexamethasone suppression test to determine the tumoural nature of an oestrogen excess of adrenal origin.
